Nuffield Health Glasgow Hospital has become the first independent hospital in Scotland to offer a single injection treatment for knee pain associated with osteoarthritis.
The treatment, nSTRIDE®APS, uses proteins drawn from the patient’s own blood to help relieve pain and restore balance by blocking the ‘bad proteins’ responsible for the inflammatory joint condition.
Clinical studies have shown the treatment can result in a 70% improvement in knee pain and suggest that a single injection can be effective for up to 36 months and, potentially, up to five years.
The treatment is particularly beneficial for patients who are not suitable for knee surgery and includes a personalised care plan which connects to Nuffield Health Glasgow Hospital’s rehabilitation services.
Jibu John Joseph, consultant orthopaedic surgeon at the hospital, said the treatment had been shown to have significantly greater reported benefits than other injections, such as corticosteroids and hyaluronic acid.
‘For many years patients with mild-to-moderate osteoarthritis have had to suffer from symptoms and functional restriction without the possibility of a suitable treatment. nSTRIDE®APS is a revolutionary treatment that utilises your own blood to generate a sample of anti-inflammatory proteins and growth factors that helps restore the balance between cartilage generation and degeneration within your joint. nSTRIDE®APS has been shown to provide significant pain relief in the majority of patients for a period of up to three years (in current studies some even have pain relief up to five years,’ he said.